-
James R. Downing, M.D., of St. Jude, elected to the American Academy of Arts and Sciences
St. Jude Children’s Research Hospital president and CEO joins the 236th class of members, which includes national and international scholars, artists, philanthropists and leaders.
-
James R. Downing, M.D., of St. Jude, to advise National Cancer Moonshot Initiative
The Blue Ribbon Panel will serve as a working group for presidentially-appointed National Cancer Advisory Board.
-
Designing an irresistible flu drug
A promising anti-influenza agent may spark the development of new medicines and combat drug resistance.
-
Problems in cellular cleanup may contribute to lupus
The most common form of the autoimmune disease lupus may be linked to defects in a cell disposal process called LAP.
-
Insights into improving pneumonia vaccines
One of the deadliest living things on Earth is the pneumococcus bacterium. Insights into how it survives and spreads have profound implications for vaccine strategies.
-
Risk factors found for leukemia treatment complication
Study finds age, ancestry and genetics can influence the risk of pancreatitis, a serious chemo side effect in acute lymphoblastic leukemia patients.
-
Diagnosing CNS-PNET tumors: Beyond the microscope
Molecular techniques may beat the microscope for diagnosing CNS-PNET, an aggressive childhood brain tumor.
From Promise, Summer 2016